|
Market Closed -
Sao Paulo
23:50:38 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 63.72 BRL | +1.43% |
|
+2.51% | +11.15% |
| 08-25 | Wall Street Wants Receipts | |
| 08-25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Chart: Technical Analysis
Stock exchange
Sao Paulo
GILD34 63.72 R$
+1.43%
28.29K
R$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| GILD | 148.77USD | +1.38% | 689M $ | |
CBOE
| GILD | 148.76USD | +1.36% | 24.07M $ | |
Börse Stuttgart
| GIS | 127.40EUR | +1.50% | 129K € | |
Wiener Boerse
| GILD | 124.90EUR | -0.95% | 26.48K € | |
London S.E.
| 0QYQ | 146.50USD | 0.00% | 19.48K $ | |
CBOE
| 0QYQ | 126.24EUR | +1.01% | 13.26K € | |
Lima
| GILDUS | 147.11USD | +5.90% | 6.47K $ | |
Tradegate
| GIS | 127.10EUR | -0.24% | 1.65K € | |
CBOE
| 126.44EUR | +1.40% | 1.39K € | ||
Xetra
| GIS | 127.14EUR | +0.28% | 1.4K € | |
Boerse Muenchen
| GIS | 127.16EUR | -0.02% | 890.12 € | |
Mexican S.E.
| GILD * | 2,520.00MXN | +1.82% | 17.64K $ | |
Borsa Italiana
| 1GILD | 119.00EUR | +0.22% | 0 € | |
Santiago S.E.
| GILD | 138.92USD | 0.00% | 0 $ | |
Swiss Exchange
| GILD | 147.16USD | +0.62% | 0 $ | |
Santiago S.E.
| GILDCL | 134,210.00CLP | +5.68% | 0 $ | |
Swiss Exchange
| GILD | 118.14CHF | +0.85% | 0 CHF | |
Deutsche Boerse AG
| GIS | 127.26EUR | +0.05% | 0 € | |
Sao Paulo
| GILD34 | 63.72BRL | +1.43% | 28.29K R$ | |
Buenos Aires S.E.
| GILD | 59,500.00ARS | +1.54% | 28.56M $ | |
Buenos Aires S.E.
| GILDD | 38.60USD | +5.01% | 5.25K $ | |
Toronto S.E.
| GILD | 30.02CAD | +1.35% | 106K $ | |
Deutsche Boerse AG
| GIS0 | 18.40EUR | +1.66% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GILD Stock
- GILD34 Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions

















